ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

MINOCIN
Acne
Bacterial infections
Protozoal infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

MINOCIN Rx

Generic Name and Formulations:
Minocycline (as HCl) 50mg, 75mg, 100mg; pellet-filled caps.

Company:
Valeant Pharmaceuticals, Inc

Therapeutic Use:

Indications for MINOCIN:

Adjunct in severe acne.

Adult:

Swallow whole. Take on empty stomach with fluids. 200mg once then 100mg every 12 hours; or 100–200mg once then 50mg four times daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Children:

≤8yrs: not recommended. Swallow whole. Take on empty stomach with fluids. >8yrs: 4mg/kg once then 2mg/kg (max 100mg) every 12 hours. Renal impairment (CrCl <80mL/min): max 200mg/day.

Warnings/Precautions:

Discontinue if serious dermatological reaction (eg, DRESS) or superinfection occurs. Women who are overweight or have history of intracranial hypertension. Evaluate if visual disturbance occurs. Renal impairment; monitor BUN and creatinine. Hepatic impairment. Monitor blood, renal, and hepatic function periodically. Monitor skeletal development (esp. in children). IV: monitor magnesium levels in renal impairment; and monitor closely in patients with heart block or myocardial damage. Pregnancy (Cat.D), nursing mothers: not recommended.

Interactions:

Avoid penicillins, methoxyflurane, isotretinoin. Caution with other hepatotoxic drugs. Reduced absorption with antacids containing aluminum, calcium, or magnesium and iron-containing products. May reduce effectiveness of oral contraceptives. Concomitant ergots or derivatives; increased risk of ergotism. Monitor PT with oral anticoagulants. May interfere with fluorescence test. IV (contains magnesium): avoid concomitant CNS depressants, neuromuscular blockers, cardiac glycosides.

See Also:

MINOCIN for INJECTION

Pharmacological Class:

Tetracycline antibiotic.

Adverse Reactions:

Dizziness, anorexia, nausea, vomiting, diarrhea, rash, pseudotumor cerebri, blood dyscrasias, increased BUN, interstitial nephritis, hepatotoxicity, tinnitus, tooth discoloration, hypersensitivity reactions; photosensitivity, C. difficile-associated diarrhea. IV: magnesium intoxication.

How Supplied:

Caps—60; Single-use vials—1, 10

Indications for MINOCIN:

Susceptible respiratory, genitourinary, skin and soft tissue, ear/nose/throat infections.

Adult:

Swallow whole. Take on empty stomach with fluids. 200mg once then 100mg every 12 hours; or 100–200mg once then 50mg four times daily. Syphilis: treat for 10–15 days. Meningococcal carrier state: 100mg every 12 hours for 5 days. Mycobacterium marinum infection: 100mg every 12 hours for 6–8 weeks has been used. Uncomplicated urethral, endocervical, or rectal infection w. C.trachomatis or U. urealyticum: 100mg every 12 hours for at least 7 days. For men: Uncomplicated gonococcal infection (not urethritis or anorectal): 200mg once then 100mg every 12 hours for at least 4 days; urethritis: 100mg every 12 hours for 5 days. Renal impairment (CrCl <80mL/min): max 200mg/day.

Children:

≤8yrs: not recommended. Swallow whole. Take on empty stomach with fluids. >8yrs: 4mg/kg once then 2mg/kg (max 100mg) every 12 hours. Renal impairment (CrCl <80mL/min): max 200mg/day.

Warnings/Precautions:

Discontinue if serious dermatological reaction (eg, DRESS) or superinfection occurs. Women who are overweight or have history of intracranial hypertension. Evaluate if visual disturbance occurs. Renal impairment; monitor BUN and creatinine. Hepatic impairment. Monitor blood, renal, and hepatic function periodically. Monitor skeletal development (esp. in children). IV: monitor magnesium levels in renal impairment; and monitor closely in patients with heart block or myocardial damage. Pregnancy (Cat.D), nursing mothers: not recommended.

Interactions:

Avoid penicillins, methoxyflurane, isotretinoin. Caution with other hepatotoxic drugs. Reduced absorption with antacids containing aluminum, calcium, or magnesium and iron-containing products. May reduce effectiveness of oral contraceptives. Concomitant ergots or derivatives; increased risk of ergotism. Monitor PT with oral anticoagulants. May interfere with fluorescence test. IV (contains magnesium): avoid concomitant CNS depressants, neuromuscular blockers, cardiac glycosides.

See Also:

MINOCIN for INJECTION

Pharmacological Class:

Tetracycline antibiotic.

Adverse Reactions:

Dizziness, anorexia, nausea, vomiting, diarrhea, rash, pseudotumor cerebri, blood dyscrasias, increased BUN, interstitial nephritis, hepatotoxicity, tinnitus, tooth discoloration, hypersensitivity reactions; photosensitivity, C. difficile-associated diarrhea. IV: magnesium intoxication.

How Supplied:

Caps—60; Single-use vials—1, 10

Indications for MINOCIN:

Adjunct in acute intestinal amebiasis.

Adult:

Swallow whole. Take on empty stomach with fluids. 200mg once then 100mg every 12 hours; or 100–200mg once then 50mg four times daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Children:

≤8yrs: not recommended. Swallow whole. Take on empty stomach with fluids. >8yrs: 4mg/kg once then 2mg/kg (max 100mg) every 12 hours. Renal impairment (CrCl <80mL/min): max 200mg/day.

Warnings/Precautions:

Discontinue if serious dermatological reaction (eg, DRESS) or superinfection occurs. Women who are overweight or have history of intracranial hypertension. Evaluate if visual disturbance occurs. Renal impairment; monitor BUN and creatinine. Hepatic impairment. Monitor blood, renal, and hepatic function periodically. Monitor skeletal development (esp. in children). IV: monitor magnesium levels in renal impairment; and monitor closely in patients with heart block or myocardial damage. Pregnancy (Cat.D), nursing mothers: not recommended.

Interactions:

Avoid penicillins, methoxyflurane, isotretinoin. Caution with other hepatotoxic drugs. Reduced absorption with antacids containing aluminum, calcium, or magnesium and iron-containing products. May reduce effectiveness of oral contraceptives. Concomitant ergots or derivatives; increased risk of ergotism. Monitor PT with oral anticoagulants. May interfere with fluorescence test. IV (contains magnesium): avoid concomitant CNS depressants, neuromuscular blockers, cardiac glycosides.

See Also:

MINOCIN for INJECTION

Pharmacological Class:

Tetracycline antibiotic.

Adverse Reactions:

Dizziness, anorexia, nausea, vomiting, diarrhea, rash, pseudotumor cerebri, blood dyscrasias, increased BUN, interstitial nephritis, hepatotoxicity, tinnitus, tooth discoloration, hypersensitivity reactions; photosensitivity, C. difficile-associated diarrhea. IV: magnesium intoxication.

How Supplied:

Caps—60; Single-use vials—1, 10

Sign Up for Free e-Newsletters

CME Focus